0283-1023Level 3
CEO-TWO (Laxative)
**Product type:** Human Otc Drug
**Active ingredient:** POTASSIUM BITARTRATE; SODIUM BICARBONATE
**Strength:** .9; .6 g/5.7g; g/5.7g
**Dosage form:** Suppository
**Route:** Rectal
**Labeler:** Beutlich Pharmaceuticals, LLC
**Marketing category:** OTC MONOGRAPH DRUG (M007)
**Pharmacologic class:** Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0283-1023Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.